MIAMI, March 15, 2012 (GLOBE NEWSWIRE) -- IFS (OTC:IFIX) announced today that it has begun its initial launch of its Large Cannulated Screw System and a Temporary External Fixator System. An Ilizerov Type Fixator System is pending FDA 510(k) clearance and it is anticipated to be released in the next quarter.
"These new product offerings expand our growing product portfolio," says CEO Stephen Dresnick, MD. "Our goal is to offer a full line of value priced, high quality orthopedic implants that meet surgeons' needs and hospital budgets. With Medicare including implants as part of a global fee as opposed to reimbursing them separately, there is a growing need to better manage implant costs. IFS wants to be part of the solution."
IFS currently offers a full line of Mini-Cannulated Screws used for small bone fixation as well as a Modular Locking Small Fragment System that contains locking plates and screws. For more information on our product offerings, please visit our website at www.ifsusa.net
About IFS: Internal Fixation Systems, Inc is a manufacturer and marketer of high quality, responsibly priced orthopedic implants and podiatric implants. We seek to prove that superior products and lower costs can go hand in hand. IFS focuses on widely used, market proven products used to treat common fractures. Our Advisory Panel, consisting of nationally recognized surgeons, provides input on how to improve our implant designs. The resulting products incorporate doctor requested enhancements and are priced at 40-60% less than the competition. IFS customers include ambulatory surgery centers, hospitals and orthopedic surgeons. Please contact us for more information about our product and business model.
Make sure you are first to receive timely information on Internal Fixation Systems when it hits the newswire. Sign up for IFS's email news alert system today at http://www.internalfixations.com/alerts.